Nanjing Delova Biotech Co., Ltd.
PrivateLast Round
Series B
Extension
Apr 2, 2024
Total Funding Raised
$51.35M
Company Overview
Nanjing Delova Biotech Co., Ltd. is a biopharmaceutical company that develops innovative, non-opioid analgesic drug formulations and long-acting injection technology platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing Delova Biotech Co., Ltd. Comparables
Compare Nanjing Delova Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hyloris Pharmaceuticals | 77% | |
| Heron Therapeutics Inc. | 77% | |
| Luye Pharma Group | 76% | |
Nanjing Delova Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 2, 2024 | ||||
| Series B | Jan 1, 2023 | ||||
| Series A | Jun 16, 2021 | ||||
| Pre Seed | Sep 14, 2020 | ||||
| Angel | Aug 25, 2017 |
Nanjing Delova Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongqi Capital | Series B Extension |
| Legend Capital | Series A, Pre Seed |
| Shengjing Jiacheng | Series B Extension |
| MPC | Series A |
| Yingdi Capital | Angel, Pre Seed |
| Hyfinity Investments | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2017
Yingdi Capital participated in the Angel round.
Nanjing Delova Biotech Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanjing Delova Biotech Co., Ltd.'s valuation, stock price, and market status.